Drug General Information
Drug ID	D01EBJ
Former ID	DIB012167
Drug Name	4991W93
Drug Type	Small molecular drug
Indication	Migraine [ICD9: 346; ICD10:G43]		Discontinued in Phase 2	[546577]
Company	Glaxo Wellcome plc
Structure		Download 2D MOL 3D MOL
Formula	C18H23N3O2
Canonical SMILES	c1(c2c([nH]c1)ccc(c2)C[C@@H]1NC(=O)OC1)[C@@H]1C[C@H](C1<br />)N(C)C
CAS Number	CAS 171549-56-7
PubChem Compound ID	9818279
Target and Pathway
Target(s)	Sodium channel	Target Info	Modulator	[531151]
KEGG Pathway	Dopaminergic synapse
Reactome	Interaction between L1 and Ankyrins
References
Ref 546577	Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800009029)
Ref 531151	CGRP and its receptors provide new insights into migraine pathophysiology. Nat Rev Neurol. 2010 Oct;6(10):573-82.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.